Glycemicon
Swiss Biotechnology Company
Glycemicon AG is a Swiss biotechnology company developing novel products for the maintenance of normal blood sugar levels and better weight management, using new approaches that were initially developed at the University of Science & Technology ETH Zurich. The lead product is a naturally-occurring bile acid, THBA, which optimises the body fat architecture to maintain normal blood glucose homeostasis.
GLYCEMICON STANDS FOR "GLYCEMIC CONTROL"
Learn more
THBA - Our lead product
Glycemicon’s lead substance, THBA, is a type of bile acid that is naturally occurring. It optimises body fat tissue maintain of normal blood sugar levels.
Learn more
Natural products for the maintenance of normal blood sugar levels and better weight management
We combine strong expertise in adipose tissue biology, pre-diabetes and obesity with top-notch synthetic chemistry of natural products and small molecules. Close interactions with academic collaboration partners, such as the ETH in Zurich, Switzerland, will fuel our pipeline with innovative new approaches and molecules to tackle the epidemic of prediabetes and obesity.
Learn more